Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 91 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes for Health Research
Grant: MOP-191992
Honorable Tina Brozman Foundation DOD CDMRP
Grant: W81XWH-19-1-0232PCC
V Foundation for Cancer Research DOD CDMRP
Grant: W81XWH-15-1-0429
V Foundation for Cancer Research DOD CDMRP
Grant: P30 CA01687
NIH
Grant: R01 CA0784561
NIH
Grant: P01 CA080111
NCI NIH HHS
Grant: P30 CA016087
NCI NIH HHS
Grant: R01 CA078461
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P01CA080111-04
BRCA 1 ANALYSIS
FWCI
9.11
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals